ProMIS Neurosciences, Inc. (PMN) Financials

PMN Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 56.7 million 7.3 million
March 31, 2026 67.4 million 6.7 million
Dec. 31, 2025 9.2 million 10.4 million
Sept. 30, 2025 21.5 million 12.3 million

PMN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -10.4 million 408894
March 31, 2026 -12.4 million 189425
Dec. 31, 2025 -9.1 million 857.0 million
Sept. 30, 2025 -10.2 million 197147

PMN Net Income

No data available :(

PMN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 53.5 million - -
March 31, 2026 63.8 million - -
Dec. 31, 2025 6.2 million - -
Sept. 30, 2025 15.4 million - -

PMN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 9.1 million
March 31, 2026 6.5 million
Dec. 31, 2025 1.8 million
Sept. 30, 2025 1.4 million

PMN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 9.5 million 2.7 million -
March 31, 2026 - 7.0 million 1.7 million -
Dec. 31, 2025 - 9.4 million 1.4 million -
Sept. 30, 2025 2 9.8 million 2.0 million -

PMN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - -
Dec. 31, 2025 - 9.4 million
Sept. 30, 2025 - -

PMN

Price: $8.07

52 week price:
6.27
27.40

Earnings Per Share: -12.62 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 84.0 million

Links: